Prenetics names Brian J. Rosin CFO, effective Dec. 31, 2026
PRE•Prenetics named Brian J. Rosin to succeed Stephen Lo as CFO, effective Dec. 31, 2026. Rosin will serve as CFO-designate through year-end, while Lo remains with the company as a senior advisor.
1. CFO transition
Prenetics named Brian J. Rosin to succeed Stephen Lo as chief financial officer, effective Dec. 31, 2026. The board is expected to formalize Rosin’s appointment on Nov. 12, 2026; he will serve as CFO-designate through year-end.
2. Leadership roles
Rosin has served as IM8 CFO since May 2026 and previously was CFO and senior vice president of e-commerce operations at Wellbeam Consumer Health. Lo will serve as CFO through Dec. 30, 2026, then remain with Prenetics as a senior advisor.
3. IM8 structure
Prenetics said it will operate with a single CFO because IM8 represents substantially all revenue, and it will not fill a separate IM8 CFO role.
